Evidence map›Paper›PMID 40546845›Full record

ArticleGland surgery2025

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.

Riku Okamoto, Hiroshi Katoh, Kanako Naito, Tomoya Mitsuma, Yuka Ozawa, Takaaki Tokito, Mariko Kikuchi, Keishi Yamashita, Takafumi Sangai

Abstract read
In one paragraph

Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Riku OkamotoDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Hiroshi KatohDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.ORCID https://orcid.org/0000-0002-2453-6278
Kanako NaitoDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Tomoya MitsumaDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Yuka OzawaDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Takaaki TokitoDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Mariko KikuchiDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.
Keishi YamashitaDivision of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Kanagawa, Japan.
Takafumi SangaiDepartment of Breast and Thyroid Surgery, Kitasato University Hospital, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: A growing body of research has recently suggested a high ratio of metastatic lymph nodes-to-harvested lymph nodes (LNR) as a robust prognostic factor in multiple solid cancers including papillary thyroid cancer (PTC). However, the clinical impact is still elusive. Accordingly, we assessed the clinical significance of LNR to select high-risk patients for recurrence. Here, LNR is described using the term "node density (ND)". Methods: Clinicopathological analyses were retrospectively conducted including pathological ND on 936 PTC patients who underwent curative resection. The clinical impact of ND was assessed based on the area and the extent of lymph node dissection. The cutoffs for variables were determined using receiver operating characteristic (ROC) curves. The cutoffs for ND were also determined using the X-tile software. Prognostic analysis was performed using Kaplan-Meier and Cox's proportional hazard models. The correlation assay was performed using multivariable logistic regression analysis. Results: Patients with recurrence had significantly higher ND than their counterparts. Patients with ND ≥17.4% showed significantly poor 10-year recurrence-free survival compared to those with lower ND (79.4% Conclusions: A high pathological ND strongly predicts an early recurrence in both early and locally advanced PTC. Thus, ND would be considered a legitimate high-risk factor in PTC patients after curative resection.

Indexed as

Lymph node densitymetastatic lymph node ratiopapillary thyroid cancer (PTC)thyroid cancer

Identifiers

PMID40546845
PMCPMC12177544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.